ArticleCureus2026
Association of Body Mass Index With Mortality and Clinical Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Medical Information Mart for Intensive Care IV (MIMIC-IV) Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNonalcoholic fatty liver disease is a common condition linked to metabolic disorders and increasing healthcare burden. The relationship between body mass index (BMI) and clinical outcomes in this population remains uncertain, with prior studies reporting mixed findings.
objectiveThis study aimed to evaluate the association between BMI and in-hospital mortality among adults with nonalcoholic fatty liver disease, with BMI analyzed as a binary variable (underweight or normal weight vs overweight or obese).
methodsThis retrospective cohort study used data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) version 3.1 database. Adult patients aged 18 years or older with nonalcoholic fatty liver disease were identified using the International Classification of Diseases (ICD) codes, and only the first hospital admission was included. BMI was calculated from recorded height and weight and categorized as underweight or normal weight versus overweight or obese. Multivariable logistic regression was used to estimate adjusted odds ratios for in-hospital mortality. Due to the low number of mortality events, a parsimonious model was applied to reduce overfitting, including age, sex, race, coronary artery disease, and chronic kidney disease as covariates.
resultsA total of 2,955 patients were included. In-hospital mortality was low, with 15 deaths observed. Overweight or obese BMI was not significantly associated with mortality compared to underweight or normal-weight BMI (adjusted odds ratio: 0.42; 95% CI: 0.14-1.27; p=0.124). Increasing age was associated with higher mortality (adjusted odds ratio: 1.05 per year; 95% CI: 1.01-1.10; p=0.024). No significant associations were observed for sex, race, coronary artery disease, or chronic kidney disease.
conclusionBMI was not associated with in-hospital mortality in patients with nonalcoholic fatty liver disease. Age was associated with increased mortality risk. These findings support the need to consider broader clinical factors beyond BMI in risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.